Common questions about Hemoclar (FAQ)
Q: Is Hemoclar available over-the-counter or does it require a prescription?
A: The regulatory status of Hemoclar (Pentosan Polysulfate Sodium 0.5% cream) depends on the country's national health authority. Official French product information indicates that this topical formulation is often classified for use in self-medication. The classification may vary by region or time, and local requirements should be verified.
Q: Can Hemoclar be used for sprains or muscle aches?
A: According to the official product indications, Hemoclar is authorized as an adjunctive local treatment primarily for minor trauma, such as traumatic contusions (bruises) and superficial hematomas (a larger collection of blood under the skin). While it is generally used for minor soft tissue events, its specific authorization does not fully cover the treatment of sprains.
Q: Does Hemoclar have an odor?
A: Regulatory descriptions of the active substance, Pentosan Polysulfate Sodium, describe it as an odorless white powder. While the final cream product contains other excipients (inactive ingredients), official regulatory documents do not specify whether the finished cream has a noticeable odor.
Q: Does prolonged use of Hemoclar cause any skin issues?
A: The topical formulation is generally intended for short-term use, aligned with the resolution of minor trauma. The official regulatory safety profile does not explicitly document an increased risk of localized adverse reactions, such as itching or redness, with long-term or prolonged use.
Q: Are there different strengths or formulations of Hemoclar?
A: The standard formulation of this product is a topical cream that contains 0.5% Pentosan Polysulfate Sodium. Regulatory information does not list alternative strengths or other cream formulations for this brand name.
Q: Is Hemoclar used for internal issues or is it strictly topical?
A: Hemoclar 0.5% cream is strictly for external use. Official administration documents specify the approved route as the dermal route (cutaneous application) only.
Q: What are the ingredients listed as 'inactive' in Hemoclar?
A: Regulatory documents list the active substance, Pentosan Polysulfate Sodium, and highlight certain excipients (inactive ingredients) due to known hypersensitivity risks. These include Methyl Parahydroxybenzoate and Propylene Glycol.
Q: Is Hemoclar primarily used for swelling or discoloration?
A: The product is classified as a vasoprotective agent, and its general purpose is to provide adjunctive support for minor soft tissue trauma. Official information states it is recognized for its ability to reduce localized swelling and assist the body’s natural processes in clearing tissue congestion.
Q: Can Hemoclar be used on varicose veins or is it only for acute trauma?
A: The official therapeutic indication for Hemoclar is strictly for the adjunctive local treatment of acute minor trauma, specifically traumatic contusions (bruises) and superficial hematomas. It is not indicated for chronic venous conditions like varicose veins.
Q: What should I do if my skin becomes very red after using Hemoclar?
A: Official safety information notes that localized erythema (redness) at the application site is a potential manifestation of a rare local hypersensitivity reaction to the cream. This type of reaction is a recognized possibility, and any persistent or severe skin reaction should be brought to the attention of a healthcare professional.
Q: Is Hemoclar an anti-inflammatory cream?
A: Hemoclar is officially classified as a vasoprotective agent belonging to the pharmacological group of heparinoids for topical use. Its primary mechanism involves stabilizing the capillary barrier and regulating local circulatory function, though the official documents do not directly categorize it as an anti-inflammatory cream.
Q: Does Hemoclar help with bruising?
A: Yes, regulatory documents indicate that Hemoclar is specifically recommended as an adjunctive local treatment for traumatic contusions (bruises) and superficial hematomas.
Q: How long does the effect of one application of Hemoclar usually last?
A: The official administration protocol recommends applying the cream two to four times per day. The recommended frequency is based on maintaining the product’s effect over the course of the day, as directed by the administration schedule.
Q: Is it normal to feel a slight tingling sensation after applying Hemoclar?
A: While the regulatory list of known adverse events specifically includes localized pruritus (itching) and erythema (redness), it does not explicitly mention a 'tingling' sensation as a commonly documented reaction.
Q: Does Hemoclar leave a greasy residue on the skin?
A: The cream is formulated with a hydrophilic emollient cream base. Hydrophilic means 'water-loving,' suggesting the formulation has properties that allow it to absorb into the skin without leaving a heavy or greasy residue.
Q: Are there specific instructions for washing the area before applying Hemoclar?
A: Official application guidelines emphasize that hands should be washed thoroughly after each use of the cream. The instructions do not provide specific guidance on washing the skin area of application before use.
Q: Why is Hemoclar not recommended for use under occlusive dressings?
A: The official constraints require Hemoclar to be applied exclusively to intact skin and prohibit its use on wounds, burns, or infected lesions. This is a common precaution for topical products to prevent excessive absorption or irritation under an occlusive (airtight) dressing.
Q: What is the active mechanism of Hemoclar at a cellular level?
A: Hemoclar works by modulating specific enzymes called Ca^2+-dependent kininases. This modulation controls the local level of bradykinin, a substance that affects blood vessel walls. By doing this, the cream stabilizes the junctions between the capillary cells, which helps reduce the leakage of fluid into the tissue.
